Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiNardo

Showing results (771-780 of 1,482) with videos related to

Pageof 149
Sort By:
American Journal of Hematology|October 29, 2020
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b studyDaniel A Pollyea, Keith Pratz, Anthony Letai, et al.
Journal of Clinical Laboratory Analysis|June 27, 2018
High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotypeMarcia Regina Dezan, Valéria B Oliveira, Çarolina Nunes Gomes, et al.
International Journal of Immunogenetics|August 18, 2017
-318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patientsV B Oliveira, M R Dezan, F C A Gomes, et al.
Plos One|March 19, 2013
MUC1* ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naïve stateBenoit J Smagghe, Andrew K Stewart, Mark G Carter, et al.
Nutrients|June 27, 2024
Exploring the Role of Lactoferrin in Managing Allergic Airway Diseases among Children: Unrevealing a Potential BreakthroughAlessandra Gori, Giulia Brindisi, Maria Daglia, et al.
Expert Opinion on Biological Therapy|June 22, 2026
Biological drugs for the treatment of children with atopic dermatitisMattia Giovannini, Leticia de Las Vecillas, Maria De Filippo, et al.
American Journal of Hematology|April 6, 2022
Prediction of survival with intensive chemotherapy in acute myeloid leukemiaKoji Sasaki, Farhad Ravandi, Tapan Kadia, et al.
Blood Advances|January 4, 2018
Copy number alterations detected as clonal hematopoiesis of indeterminate potentialKoichi Takahashi, Feng Wang, Hagop Kantarjian, et al.
Transfusion|June 25, 2020
Blood utilization and characteristics of patients treated with chronic transfusion therapy in a large cohort of Brazilian patients with sickle cell diseaseShannon Kelly, André Rolim Belisário, Daniela O Werneck Rodrigues, et al.
Cancer Research|March 2, 2018
Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 InhibitionJo Ishizawa, Kenji Nakamaru, Takahiko Seki, et al.
Pageof 149

Showing results (771-780 of 1,482) with videos related to

Sort By:
Pageof 149
American Journal of Hematology|October 29, 2020
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b studyDaniel A Pollyea, Keith Pratz, Anthony Letai, et al.
Journal of Clinical Laboratory Analysis|June 27, 2018
High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotypeMarcia Regina Dezan, Valéria B Oliveira, Çarolina Nunes Gomes, et al.
International Journal of Immunogenetics|August 18, 2017
-318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patientsV B Oliveira, M R Dezan, F C A Gomes, et al.
Plos One|March 19, 2013
MUC1* ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naïve stateBenoit J Smagghe, Andrew K Stewart, Mark G Carter, et al.
Nutrients|June 27, 2024
Exploring the Role of Lactoferrin in Managing Allergic Airway Diseases among Children: Unrevealing a Potential BreakthroughAlessandra Gori, Giulia Brindisi, Maria Daglia, et al.
Expert Opinion on Biological Therapy|June 22, 2026
Biological drugs for the treatment of children with atopic dermatitisMattia Giovannini, Leticia de Las Vecillas, Maria De Filippo, et al.
American Journal of Hematology|April 6, 2022
Prediction of survival with intensive chemotherapy in acute myeloid leukemiaKoji Sasaki, Farhad Ravandi, Tapan Kadia, et al.
Blood Advances|January 4, 2018
Copy number alterations detected as clonal hematopoiesis of indeterminate potentialKoichi Takahashi, Feng Wang, Hagop Kantarjian, et al.
Transfusion|June 25, 2020
Blood utilization and characteristics of patients treated with chronic transfusion therapy in a large cohort of Brazilian patients with sickle cell diseaseShannon Kelly, André Rolim Belisário, Daniela O Werneck Rodrigues, et al.
Cancer Research|March 2, 2018
Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 InhibitionJo Ishizawa, Kenji Nakamaru, Takahiko Seki, et al.
Pageof 149